Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
21,352
Total Claims
$1.7M
Drug Cost
948
Beneficiaries
$1,759
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+50%
Cost per patient vs peers
$1,759 vs $1,174 avg
+37%
Brand preference vs peers
12.1% vs 8.9% avg
Brand vs Generic
Brand: 2,534 claims · $1.3M
Generic: 18,385 claims · $375K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 156 | $178K |
| Insulin Glargine,hum.Rec.Anlog | 190 | $99K |
| Linagliptin | 52 | $84K |
| Sitagliptin Phosphate | 62 | $84K |
| Rivaroxaban | 52 | $73K |
| Bictegrav/Emtricit/Tenofov Ala | 14 | $57K |
| Budesonide/Formoterol Fumarate | 112 | $50K |
| Empagliflozin | 23 | $39K |
| Linaclotide | 28 | $33K |
| Dulaglutide | 25 | $31K |
| Ticagrelor | 26 | $25K |
| Sitagliptin Phos/Metformin Hcl | 14 | $25K |
| Dapagliflozin Propanediol | 20 | $22K |
| Atorvastatin Calcium | 1,786 | $22K |
| Sacubitril/Valsartan | 17 | $22K |
Prescribing Profile
Patient Profile
74
Avg Age
59%
Female
2.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data